Found 8 matching trials
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies PHASE1 The purpose of this study is to assess the safety and efficacy of surovatam...
Show More Learn More & Join Trial
A Study Comparing a New Drug (Surovatamig) With Standard Radiotherapy With or Without Rituximab in Adults With Limited Stage Nodal Follicular Lymphoma PHASE3 The goal of this clinical trial is to learn if surovatamig works better tha...
Show More Location
Multiple Locations
Learn More & Join Trial
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia PHASE1 This is a Phase 1/2, global multicentre, open-label, single-arm, dose escal...
Show More Learn More & Join Trial
Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants PHASE1 This open-label, Phase I study will assess the safety and tolerability of s...
Show More Learn More & Join Trial
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients PHASE3 This is a global, randomised, Phase III, multicentre, open-label study eval...
Show More Learn More & Join Trial
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL PHASE2 This is a Phase 2 global, multi-center, open-label study to assess the effi...
Show More Learn More & Join Trial
A Study to Assess the Effect of Surovatamig in Adult Participants With Antibody-mediated Kidney Disease PHASE2 The purpose of this study is to assess the safety, tolerability, pharmacoki...
Show More Learn More & Join Trial
Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV) PHASE3 The purpose of this study is to evaluate the therapeutic benefit and safety...
Show More Learn More & Join Trial